BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36203070)

  • 1. TRIM47 promotes glioma angiogenesis by suppressing Smad4.
    Wang Z; Li Z; Han C; Cheng Y; Wang K
    In Vitro Cell Dev Biol Anim; 2022 Oct; 58(9):771-779. PubMed ID: 36203070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.
    Chen L; Li M; Li Q; Xu M; Zhong W
    Mol Cell Probes; 2020 Oct; 53():101623. PubMed ID: 32603762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
    Ji B; Liu L; Guo Y; Ming F; Jiang J; Li F; Zhao G; Wen J; Li N
    Comput Math Methods Med; 2021; 2021():5594973. PubMed ID: 33833824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
    Wang Y; Liu C; Xie Z; Lu H
    Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling.
    Wang X; Fu Y; Xing Y
    Clinics (Sao Paulo); 2022; 77():100122. PubMed ID: 36288633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑24 regulates angiogenesis in gliomas.
    Dai D; Huang W; Lu Q; Chen H; Liu J; Hong B
    Mol Med Rep; 2018 Jul; 18(1):358-368. PubMed ID: 29749450
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wei H; Ding C; Zhuang H; Hu W
    Onco Targets Ther; 2020; 13():13401-13411. PubMed ID: 33408486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer.
    Fujimura T; Inoue S; Urano T; Takayama K; Yamada Y; Ikeda K; Obinata D; Ashikari D; Takahashi S; Homma Y
    Clin Genitourin Cancer; 2016 Aug; 14(4):298-303. PubMed ID: 26873435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
    Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat Shock Protein 47 Promotes Glioma Angiogenesis.
    Wu ZB; Cai L; Lin SJ; Leng ZG; Guo YH; Yang WL; Chu YW; Yang SH; Zhao WG
    Brain Pathol; 2016 Jan; 26(1):31-42. PubMed ID: 25758142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piezo2 protein: A novel regulator of tumor angiogenesis and hyperpermeability.
    Yang H; Liu C; Zhou RM; Yao J; Li XM; Shen Y; Cheng H; Yuan J; Yan B; Jiang Q
    Oncotarget; 2016 Jul; 7(28):44630-44643. PubMed ID: 27329839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression.
    Tan Z; Chen K; Wu W; Zhou Y; Zhu J; Wu G; Cao L; Zhang X; Guan H; Yang Y; Zhang W; Li J
    Theranostics; 2018; 8(18):5143-5158. PubMed ID: 30429891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus encoding Smad4 suppresses glioma cell proliferation and increases apoptosis through cell cycle arrest at G1 phase.
    Yang Z; Zhong L; Zhong S; Xian R; Yuan B
    Int Immunopharmacol; 2015 Mar; 25(1):169-73. PubMed ID: 25639227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2.
    Lang HL; Hu GW; Zhang B; Kuang W; Chen Y; Wu L; Xu GH
    Oncol Rep; 2017 Aug; 38(2):785-798. PubMed ID: 28656228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer.
    Li L; Yu Y; Zhang Z; Guo Y; Yin T; Wu H; Yang M
    Pharmacol Res; 2021 Apr; 166():105429. PubMed ID: 33529753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153.
    Ma Y; Xue Y; Liu X; Qu C; Cai H; Wang P; Li Z; Li Z; Liu Y
    Oncol Rep; 2017 Nov; 38(5):3265-3277. PubMed ID: 29048682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
    Jiang J; Lu J; Wang X; Sun B; Liu X; Ding Y; Gao G
    Aging (Albany NY); 2021 Jul; 13(15):19243-19259. PubMed ID: 34233294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.